Michael Chrobok
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 8
- CAR-T cell therapy research 7
-
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 2
- T-cell and B-cell Immunology 2
- Co-authors
- Evren Alici (8 shared papers)Adil Doganay Duru (5 shared papers)Carin Dahlberg (2 shared papers)Dhifaf Sarhan (1 shared paper)Arnika Kathleen Wagner (4 shared papers)Hareth Nahi (2 shared papers)Gösta Gahrton (1 shared paper)Johan Lund (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Cancers (2 papers)Stem Cell Reports (1 paper)PLoS ONE (1 paper)European Journal of Immunology (1 paper)
- Partner nations
- SwedenUnited StatesTürkiye
In The Last Decade
Michael Chrobok
11 papers receiving 445 citations
Peers
Comparison fields: 5 of 67
- Immunology 233
- Oncology 224
- Hematology 70
- Hepatology 17
- Genetics 23
Countries citing papers authored by Michael Chrobok
This map shows the geographic impact of Michael Chrobok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chrobok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chrobok more than expected).
Fields of papers citing papers by Michael Chrobok
This network shows the impact of papers produced by Michael Chrobok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chrobok. The network helps show where Michael Chrobok may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Chrobok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 149 | |
| 2 | 2019 | 81 | |
| 3 | 2020 | 51 | |
| 4 | 2020 | 47 | |
| 5 | 2019 | 38 | |
| 6 | 2021 | 27 | |
| 7 | 2019 | 23 | |
| 8 | 2022 | 23 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 1 |
About Michael Chrobok
Michael Chrobok is a scholar working on Oncology, Immunology, Molecular Biology, Biomedical Engineering and Obstetrics and Gynecology, having authored 11 papers that have together received 457 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Nanowire Synthesis and Applications (1 paper), Endometriosis Research and Treatment (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (233 citations), Oncology (224 citations), Hematology (70 citations), Hepatology (17 citations) and Genetics (23 citations). Michael Chrobok has collaborated with scholars based in Sweden, United States and Türkiye. Frequent co-authors include Evren Alici, Adil Doganay Duru, Carin Dahlberg, Dhifaf Sarhan, Arnika Kathleen Wagner, Hareth Nahi, Gösta Gahrton, Johan Lund, Per Ljungman and Astrid Gruber. Their work appears in journals such as Frontiers in Immunology, Cancers, Stem Cell Reports, PLoS ONE and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.